Physician profile
Kenneth E Schmanke
NPI 1316571623
$1,950.75
in general payments reported to CMS, 2019-2025
12 companies · $459 in 2025
The $459 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $345 · 2022: $174 · 2023: $67.98 · 2024: $905 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056 · Travel and Lodging: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.13 |
| Travel and Lodging | $375.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,482.71 | 2021-2025 | Ams 700, Tactra |
| Teleflex LLC | $104.36 | 2021 | |
| Ethicon US, LLC | $74.01 | 2021 | |
| Rochester Medical Corporation | $60.65 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $53.35 | 2025 | Adstiladrin |
| Immunitybio, INC. | $36.95 | 2025 | |
| Progenics Pharmaceuticals, INC. | $34.78 | 2025 | |
| Intuitive Surgical, INC. | $29.77 | 2024 | |
| Angiodynamics, INC. | $22.92 | 2025 | Nanoknife |
| Pfizer INC. | $17.56 | 2025 | |
| Convatec INC. | $17.56 | 2021 | |
| Baxter Healthcare | $16.13 | 2024 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Schmanke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.